CAS: 60656-87-3; 2-(Benzyloxy)Acetaldehyde

该化合物是一种有机化合物,其特征是存在甲醚功能组和醚联系,其特征是附属于甲氧基组的苯基组,该组与甲代丁二烯杂酸有进一步的联系,该组通常具有中度的沸点,在室温下可能无色可粉黄的黄色液体,其结构表明它可能具有一种令人愉快的芳香味,这是许多苯丙基化合物的特征. (苯丙基)乙酰胺在有机溶剂中溶解,其再活性受甲代基组的影响,使其易受氧化和核分裂性攻击.该组可能会在有机合成,芳香配方或作为其他化学物质生产的中间体中发现应用.与许多有机化合物一样,适当的处理和安全防范措施对于潜在的毒性和再活性至关重要.

结构式图片

欧盟法规

REACH注册ECHA物质C&L通报REACH预注册

上下游产品

CAS号68972-96-3 顺-1,4-二苄氧基-2-丁烯 | CAS号42783-78-8 苄氧基乙醛缩二乙醇 | CAS号69010-01-1 meso-1,4-bis(be... | CAS号622-08-2 2-苄氧基乙醇 | CAS号13071-59-5 (R)-(+)-1-苄基丙三醇 | CAS号14593-43-2 烯丙基苄基醚 | CAS号80885-30-9 (E)-4-[(Benzyl)... | CAS号75-09-2 二氯甲烷 | CAS号104322-67-0 (2S,3s)-2-苄氧基-3... | CAS号58081-05-3 (R)-3-羟基-gamma-丁内酯 | CAS号5469-16-9 (+/-)-β-羟基-γ-丁内酯 | CAS号14869-00-2 1-(Benzyloxy)-2... | CAS号188896-08-4 2-(BENZYLOXY)-1... | CAS号30379-54-5 2-(苄氧基)乙酸苄酯 | CAS号22539-93-1 苄氧基丙酮 | CAS号622-08-2 2-苄氧基乙醇 | CAS号72432-03-2 米各尼醇 | CAS号101376-73-2 methyl 2-methyl...

合成工艺路线路线简述

  • 合成目标产物 Benzyloxyacetaldehyde 主要起始原料 2-Benzyloxyethanol
  • (文献来源)合成步骤主要原料 2-Benzyloxyethanol
甲基苯醌置于potassium Hydride,臭氧,三苯基膦体系中,化学反应 13.5H,反应生成 苄氧基乙醛
参考文献:A Route To The Pyrrolo[1,2-A]Indolenine Ring System Via Intermolecular Organolithium Addition To An Oxindole
标题:A Route To The Pyrrolo[1,2-A]Indolenine Ring System Via Intermolecular Organolithium Addition To An Oxindole
摘要:A Synthesis Of The Pyrrolo[1,2 A]Indolenine 6 In Four Steps From N-Benzyl-3,3-Dimethyloxindole 2 Is Presented Involving An Organolithium Addition To The Oxindole Carbonyl Group. Additions Of Vinyllithiums To The Oxindole 2 Are Presented.
DOI:10.1016/s0040-4020(01)80407-5

海关参考信息

专利信息


专利号:US-6069250-A
优先权日:1995-12-14
标 题 :Method and compositions for the synthesis of dioxolane nucleosides with β-configuration
发明人:MANSOUR TAREK; CIMPOIA ALEX; BEDNARSKI KRZYSZTOF
权利人:IAF BIOCHEM INT
摘要:The present invention relates to methods and compositions for preparing biologically important nucleoside analogues containing 1,3-dioxolane sugar rings. In particular, this invention relates to the stereoselective synthesis of the beta (cis) isomer by glycosylating the base with an intermediate of formula (II) below a temperature of about -10 DEG C. wherein R1 and L are as defined herein.

专利号:EP-2465936-A1
优先权日:2010-12-20
标题 :Enzymatic synthesis of statins and intermediates thereof
权利人:LEK PHARMACEUTICALS
摘要:The present invention discloses a process for preparing an active pharmaceutical ingredient (API) or intermediates thereof, notably particular step in the synthesis of an intermdiate useful for example in the preparation of statins, by using an enzyme capable of catalyzing oxidation or dehydrogenation. The invention further provides an expression system effectively translating said enzyme. In addition, the invention relates to a specific use of such enzyme for preparing API or intermediate thereof, and in particular for preparing statin or interemediate thereof.

专利号:US-7541456-B2
优先权日:2002-04-19
标题:Direct, enantioselective aldol coupling of aldehydes using chiral organic catalysts
发明人:MACMILLAN DAVID W C; NORTHRUP ALAN B
权利人:CALIFORNIA INST OF TECHN
摘要:Nonmetallic, chiral organic catalysts are used to catalyze an enantioselective aldol coupling reaction between aldehyde substrates. The reaction may be carried out with a single enolizable aldehyde, resulting in dimerization to give a β-hydroxy aldehyde, or trimerization to give a dihydroxy tetrahydropyran. The reaction may also conducted with an enolizable aldehyde and a second aldehyde, which may or may not be enolizable, so that the coupling is a cross-aldol reaction in which the α-carbon of the enolizable aldehyde adds to the carbonyl carbon of the second aldehyde in an enantioselective fashion. Reaction systems composed of at least one enolizable aldehyde, an optional additional aldehyde, and the nonmetallic chiral organic catalyst are also provided, as are methods of implementing the enantioselective aldol reaction in the synthesis of sugars.

专利号:WO-9946267-A1
优先权日:1998-03-12
标题 :Modulators of protein tyrosine phosphatases (ptpases)
发明人:MOELLER NIELS PETER HUNDAHL; ANDERSEN HENRIK SUNE; IVERSEN LARS FOGH; OLSEN OLE HVILSTED; BRANNER SVEN; HOLSWORTH DANIEL DALE; BAKIR FARID; JUDGE LUKE MILBURN; AXE FRANK URBAN; JONES TODD KEVIN; RIPKA WILIAM CHARLES; GE YU; UYEDA ROY TERUYUKI
权利人:NOVO NORDISK AS; ONTOGEN CORP
摘要:The present invention provides novel compounds, novel compositions, methods of their use, and methods of their manufacture, where such compounds are pharmacologically useful inhibitors of Protein Tyrosine Phosphatases (PTPases) such as PTP1B, CD45, SHP-1, SHP-2, PTPα, LAR and HePTP or the like. The compounds are useful in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance, obesity, immune dysfunctions including autoimmunity diseases with dysfunctions of the coagulation system, allergic diseases including asthma, osteoporosis, proliferative disorders including cancer and psoriasis, diseases with decreased or increased synthesis or effects of growth hormone, diseases with decreased or increased synthesis of hormones or cytokines that regulate the release of/or response to growth hormone, diseases of the brain including Alzheimer's disease and schizophrenia, and infectious diseases.

专利号:US-6951878-B2
优先权日:1998-03-12
标 题:Benzo[b]thiophenyl or tetrahydro-benzo[b]thiophenyl modulators of protein tyrosine phosphatases (PTPases)
发明人:MOELLER NIELS PETER HUNDAHL; ANDERSEN HENRIK SUNE; IVERSEN LARS FOGH; OLSEN OLE HVILSTED; BRANNER SVEN; HOLSWORTH DANIEL DALE; BAKIR FARID; JUDGE LUKE MILBURN; AXE FRANK URBAN; JONES TODD KEVIN; RIPKA WILLIAM CHARLES; GE YU; UYEDA ROY TERUYUKI
权利人:NOVO NORDISK AS
摘要:The present invention provides novel compounds, novel compositions, methods of their use, and methods of their manufacture, where such compounds are pharmacologically useful inhibitors of Protein Tyrosine Phosphatases (PTPase's) such as PTP1B, CD45, SHP-1, SHP-2, PTPα, LAR and HePTP or the like. n The compounds are useful in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance, obesity, immune dysfunctions including autoimmunity diseases with dysfunctions of the coagulation system, allergic diseases including asthma, osteoporosis, proliferative disorders including cancer and psoriasis, diseases with decreased or increased synthesis or effects of growth hormone, diseases with decreased or increased synthesis of hormones or cytokines that regulate the release of/or response to growth hormone, diseases of the brain including Alzheimer's disease and schizophrenia, and infectious diseases.

专利号:US-9243002-B2
优先权日:2013-02-07
标题 :Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C
发明人:DAI XING; LIU HONG; PALANI ANANDAN; HE SHUWEN; BROCKUNIER LINDA L; NARGUND RAVI; MARCANTONIO KAREN; ZORN NICOLAS; XIAO DONG; PENG XUANJIA; LI PENG; GUO TAO
权利人:MERCK SHARP & DOHME
摘要:The present invention relates to compounds of formula I that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.
上海创拓生物科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.chuangtuobio.com
电话: 021-64301660 18121244935👤
📞上海创拓生物科技有限公司 ⚠️参考联系方式

销售电话:021-64301660 18121244935
邮箱:sales@chuangtuobio.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:金山区学府路1379弄100号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
阜新达得利化工股份有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.dudleychem.com
企业联系电话:17741815008;13695005683👤
📞阜新达得利化工股份有限公司 ⚠️参考联系方式
联系人:王总
电话:17741815008;13695005683
手机:18641848178
传真:0418-8229996
邮箱:office@dudleychem.com
通信地址: 辽宁省阜新县伊吗图氟产业开发区
邮编: 123000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:辽宁省阜新县伊吗图氟产业开发区
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献

参考标题:Total Synthesis Of The Macrolide Antibiotic Cytovaricin
作者:David A. Evans,Stephen W. Kaldor,Todd K. Jones,Jon Clardy,Thomas J. Stout |发布日期:1990.9
摘要:A Convergent Asymmetric Synthesis Of The Antinoeplastic Macrolide Antibiotic Cytovaricin Has Been Achieved Through The Synthesis And Coupling Of The Illustrated Spiroketal And Polyol Glycoside Subunits. All Absolute Steroechemical Relationships Within The Target Structure Were Ultimately Controlled By The Use Of Asymmetric Aldol, Alkylation, Or Epoxidation Methodology. Union Of The Two Subnits Was

合成参考文献


摘要:Li, W.; Liu, X. H.; Feng, X. M., Science of Synthesis Knowledge Updates, (2021) 1, 48.
摘要:Wu, X.-F., Science of Synthesis Knowledge Updates, (2014) 1, 255.
摘要:Matsunaga, S., Science of Synthesis Knowledge Updates, (2010) 4, 209.
摘要:Snaith, J. S., Science of Synthesis Knowledge Updates, (2011) 2, 250.
摘要:Khartulyari, A.; Maier, M. E., Science of Synthesis Knowledge Updates, (2010) 3, 100.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知